An examination of the role of MAP3K19 in the COPD disease process revealed that inhibition of MAP3K19 by either siRNA or small molecule inhibitors strongly decreased the cigarette smoke-induced pulmonary inflammation in an acute model. The gene discussed is MAP3K19; the disease is chronic obstructive pulmonary disease.